first-pass metabolism

First-pass metabolism (also called the first-pass effect) describes what happens to an orally ingested drug before it ever reaches general circulation. After a substance is swallowed and absorbed through the gut wall, it travels directly to the liver via the portal vein. Liver enzymes then metabolize a portion of it — sometimes a substantial one — before it can circulate to the rest of the body.

The fraction that survives this process is the drug's oral bioavailability. A substance with heavy first-pass metabolism may be far less potent by mouth than by other routes: injected, inhaled, or dissolved under the tongue. This gap between ingested dose and effective dose is one of the most practically important ideas in pharmacology.

How it works · its role

The primary engines of first-pass metabolism are the cytochrome P450 enzymes — a large family of proteins concentrated in the liver and, to a lesser degree, the intestinal wall. These enzymes evolved to detoxify foreign compounds, and they metabolize many drugs as a byproduct of that function.

For most drugs, first-pass conversion produces inactive or less active metabolites, blunting the effect of each oral dose. For others, the liver does the opposite: it converts an inert precursor into the active compound. Substances designed around this are called prodrugs, and their activation depends on first-pass processing working as intended.

The degree of first-pass extraction is not fixed. Genetic variation in enzyme expression means two people can metabolize the same oral dose very differently. Liver enzyme activity can also be raised or lowered by other substances taken at the same time — a significant source of drug interactions.

Relevance to substances & effects

First-pass metabolism shapes the effective potency of a wide range of psychoactive substances. Opioids such as morphine undergo extensive first-pass conversion, which is why oral doses are considerably higher than equivalent doses by other routes. Benzodiazepines vary widely in this respect: some are absorbed with relatively little first-pass loss; others depend on hepatic conversion to generate their active metabolites.

Some psychedelic prodrugs — psilocybin being the clearest example — actually rely on enzymatic conversion in the gut and liver to yield their active form. Here, first-pass processing is part of the mechanism rather than an obstacle to it.

Many administration routes exist specifically to circumvent first-pass metabolism. Sublingual and buccal dosing allows absorption directly through the mucous membranes of the mouth; transdermal patches deliver a drug through the skin; inhalation carries compounds across the lungs. Each of these paths bypasses the portal circulation, delivering more drug per unit dose and typically producing faster onset.